Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPOKAL: Switching EFV to LPV/r for HIV-associated Lipoatrophy
NCT00978237Phase 4Completed
- Start
- Oct 2009
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV). Started Oct 2009; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00978237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978237.